2023
Dose-Escalated vs. Conventional Hypofractionated Radiotherapy for Lung Cancer Patients in Predominantly Central Locations
Sasse A, Saeed N, Oh P, Housri N, Knowlton C, Hayman T, Peters G, Campbell A, Yang D, Park H. Dose-Escalated vs. Conventional Hypofractionated Radiotherapy for Lung Cancer Patients in Predominantly Central Locations. International Journal Of Radiation Oncology • Biology • Physics 2023, 117: e55. DOI: 10.1016/j.ijrobp.2023.06.768.Peer-Reviewed Original ResearchStereotactic body radiotherapyUltra-central tumoursHypofractionated radiation therapyHigh local controlOverall survivalGrade 3Local controlLung cancerNon-small cell lung cancerPromising local controlOutcomes of patientsEffective treatment regimenCell lung cancerHigher overall survivalLung cancer patientsMATERIAL/METHODSMedian ageHypofractionated radiotherapyTreatment regimenBody radiotherapyBaseline variablesCancer patientsTreatment optionsTumor locationChi-square analysis
2009
Surgery does not adversely affect survival in primary gastrointestinal lymphoma
Cheung MC, Housri N, Ogilvie MP, Sola JE, Koniaris LG. Surgery does not adversely affect survival in primary gastrointestinal lymphoma. Journal Of Surgical Oncology 2009, 100: 59-64. PMID: 19399785, DOI: 10.1002/jso.21298.Peer-Reviewed Original ResearchConceptsGastrointestinal lymphomaMultivariate analysisMarginal zone B-cell lymphomaAssociated survival benefitPrimary gastrointestinal lymphomaEnd Results (SEER) databaseImpact of surgeryRisk of deathB-cell lymphomaMedian survivalOverall survivalSurgical resectionIndependent predictorsSurvival benefitOverall incidencePoor prognosisResults databaseSurgical extirpationExtirpative surgeryTumor locationMale genderUnivariate analysisSurgeryLymphomaTreatment data